Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom K Choi

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Immunotherapy|February 15, 2019
Delayed IL-21 treatment preferentially expands peptide-specific CD8<sup>+</sup> T cells by reducing bystander activation of T cellsSeon-Hee Kim, Sang-Yoon Park, Myong Cheol Lim, et al.
Cytokine|June 25, 2011
Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivoBeom K Choi, Young H Kim, Jae H Choi, et al.
European Journal of Immunology|August 24, 2018
RELT negatively regulates the early phase of the T-cell response in miceBeom K Choi, Seon-Hee Kim, Young H Kim, et al.
Cancer Research|September 19, 2007
Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapyBeom K Choi, Young H Kim, Woo J Kang, et al.
Nature Medicine|September 28, 2004
4-1BB-mediated immunotherapy of rheumatoid arthritisSu K Seo, Jae H Choi, Young H Kim, et al.
Plos One|October 3, 2012
4-1BB signaling breaks the tolerance of maternal CD8+ T cells that are reactive with alloantigensKwang H Kim, Beom K Choi, Jung D Kim, et al.
International Journal of Biological Sciences|November 10, 2025
Synergistic Effects of Radiotherapy and PD‑1 Blockade in a Human‑Mimetic BRCAness Model of Triple-Negative Breast CancerEun Ju Cho, Min Kyung Ki, Hye Jung Baek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Immune responses in 4-1BB (CD137)-deficient miceByoung S Kwon, Jose C Hurtado, Zang H Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2010
Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gammaBeom K Choi, Young H Kim, Chang H Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2015
Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are DepletedYoung H Kim, Su M Shin, Beom K Choi, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Immunotherapy|February 15, 2019
Delayed IL-21 treatment preferentially expands peptide-specific CD8<sup>+</sup> T cells by reducing bystander activation of T cellsSeon-Hee Kim, Sang-Yoon Park, Myong Cheol Lim, et al.
Cytokine|June 25, 2011
Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivoBeom K Choi, Young H Kim, Jae H Choi, et al.
European Journal of Immunology|August 24, 2018
RELT negatively regulates the early phase of the T-cell response in miceBeom K Choi, Seon-Hee Kim, Young H Kim, et al.
Cancer Research|September 19, 2007
Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapyBeom K Choi, Young H Kim, Woo J Kang, et al.
Nature Medicine|September 28, 2004
4-1BB-mediated immunotherapy of rheumatoid arthritisSu K Seo, Jae H Choi, Young H Kim, et al.
Plos One|October 3, 2012
4-1BB signaling breaks the tolerance of maternal CD8+ T cells that are reactive with alloantigensKwang H Kim, Beom K Choi, Jung D Kim, et al.
International Journal of Biological Sciences|November 10, 2025
Synergistic Effects of Radiotherapy and PD‑1 Blockade in a Human‑Mimetic BRCAness Model of Triple-Negative Breast CancerEun Ju Cho, Min Kyung Ki, Hye Jung Baek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Immune responses in 4-1BB (CD137)-deficient miceByoung S Kwon, Jose C Hurtado, Zang H Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2010
Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gammaBeom K Choi, Young H Kim, Chang H Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 2, 2015
Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are DepletedYoung H Kim, Su M Shin, Beom K Choi, et al.
Pageof 7